Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Managed Care MSLs-Past, Present and Future
Summary
In this episode, Todd Wandstrat delves into the intricate world of managed care and its intersection with the Medical Science Liaison (MSL) role. He offers a comprehensive overview of managed care's history, including health plans, PBMs, and integrated delivery networks. Todd shares insights into the evolving role of MSLs in this sector, highlighting the unique customer base and value proposition they bring. He discusses the necessary skills and career pathways for aspiring managed care MSLs, emphasizing the importance of presentation skills and resume building. The conversation also touches on navigating the MSL role during COVID, fostering KOL relationships, and the significance of internal collaboration and innovative thinking.
Check out my latest podcast with Todd Wandstrat, Sr Director of Field Based Medicine who discusses Managed Care MSLs… Past, Present and Future
Todd shares…
The historical perspective of the Managed Care Market and the MSL
What is a Managed Care MSL
What skills are mandatory and how can an MSL transition
What does the future look like for MSLs
Managed Care MSL, Health Plans, Medical Science Liaison, MSL Skills, Integrated Delivery Networks
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary